Characterization of the Puumala orthohantavirus Strains in the Northwestern Region of the Republic of Tatarstan in Relation to the Clinical Manifestations in Hemorrhagic Fever With...

por Davidyuk, Yuriy N., Kabwe, Emmanuel, Shakirova, Venera G., Martynova, Ekaterina V., Ismagilova, Ruzilya K., Khaertynova, Ilsiyar M., Khaiboullina, Svetlana F., Rizvanov, Albert A., Morzunov, Sergey P.
Publicado 2019

Long Term Immune Response Produced by the SputnikV Vaccine

por Martynova, Ekaterina, Hamza, Shaimaa, Garanina, Ekaterina E., Kabwe, Emmanuel, Markelova, Maria, Shakirova, Venera, Khaertynova, Ilsiyar M., Kaushal, Neha, Baranwal, Manoj, Rizvanov, Albert A., Urbanowicz, Richard A., Khaiboullina, Svetlana F.
Publicado 2021

Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients

por Garanina, Ekaterina, Hamza, Shaimaa, Stott-Marshall, Robert J., Martynova, Ekaterina, Markelova, Maria, Davidyuk, Yuriy, Shakirova, Venera, Kaushal, Neha, Baranwal, Manoj, Khaertynova, Ilsiyar M., Rizvanov, Albert, Foster, Toshana L., Khaiboullina, Svetlana
Publicado 2022

Urinary Clusterin Is Upregulated in Nephropathia Epidemica

por Martynova, Ekaterina V., Maksudova, Adelya N., Shakirova, Venera G., Abdulkhakov, Sayar R., Khaertynova, Ilsiyar M., Anokhin, Vladimir A., Ivanova, Vilena V., Abiola, Ilesanmi M., Garanina, Ekaterina E., Tazetdinova, Leisan G., Valiullina, Aigul H., Khaiboullina, Svetlana F.
Publicado 2018

Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococc...

por Hammitt, Laura L, Quinn, Dean, Janczewska, Ewa, Pasquel, Francisco J, Tytus, Richard, Rajender Reddy, K, Abarca, Katia, Khaertynova, Ilsiyar M, Dagan, Ron, McCauley, Jennifer, Cheon, Kyeongmi, Pedley, Alison, Sterling, Tina, Tamms, Gretchen, Musey, Luwy, Buchwald, Ulrike K
Publicado 2021

1050. Phase 3 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by 23valent Pneumococcal Polysaccharide Vaccine 6 Months Later in At-risk Adults Aged...

por Hammitt, Laura, Quinn, Dean, Janczewska, Ewa, Pasquel, Francisco J, Tytus, Richard, Rajender Reddy, K, Abarca, Katia, Khaertynova, Ilsiyar M, Dagan, Ron, Dawson, Rachel, McCauley, Jennifer, Cheon, Kyeongmi, Pedley, Alison, Sterling, Tina, Tamms, Gretchen, Musey, Luwy, Buchwald, Ulrike K
Publicado 2021

Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccin...

por Hammitt, Laura L., Quinn, Dean, Janczewska, Ewa, Pasquel, Francisco J., Tytus, Richard, Reddy, K. Rajender, Abarca, Katia, Khaertynova, Ilsiyar M., Dagan, Ron, Dawson, Rachel, McCauley, Jennifer, Shekar, Tulin, Fu, Wei, Pedley, Alison, Sterling, Tina, Tamms, Gretchen, Musey, Luwy, Buchwald, Ulrike K.
Publicado 2023